---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-004834"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:18:54.490181+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CareDx prelim FY2023 revenue $279-280M, above high end of guidance; Q4 patient volumes up 4% QoQ

## Summary
- Full-year revenue expected $279-280M, exceeding $277M high-end guidance; FY2022 was $321.8M.
- Q4 testing-services revenue $46-47M vs $47.8M in Q3; patient results ~39,900, up 4% sequentially.
- Patient & Digital Solutions FY rev ~$37M (+29% YoY); Products ~$33.5M (+14% YoY).
- Repurchased 2.8M shares for $26M; cash & equivalents $235M with no debt.
- Fifth consecutive quarter of testing-services collections above 100% of revenue.

## SEC filing metadata
- accession: 0001193125-24-004834
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/0001193125-24-004834-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/d93749d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-004834
- JSON: https://secwatch.observer/filing/0001193125-24-004834.json
- Plain text: https://secwatch.observer/filing/0001193125-24-004834.txt

## Key facts
- Earnings Releases
  CareDx, Inc. reported the fourth quarter ended December 31, 2023 results: revenue between $65 million and $66 million.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: between $65 million and $66 million
  - Result: preliminary results
  source text: Preliminary revenue for the three months ended December 31, 2023, is expected to be between $65 million and $66 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/0001193125-24-004834-index.htm
- Earnings Releases
  CareDx, Inc. reported the full year ended December 31, 2023 results: revenue between $279 million and $280 million.
  - Period: the full year ended December 31, 2023
  - Revenue: between $279 million and $280 million
  - Result: preliminary results
  source text: Preliminary revenue for the full year ended December 31, 2023, is expected to be between $279 million and $280 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000119312524004834/0001193125-24-004834-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.